Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer

Articles Ahead of Print

A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy

Volume:20
Henu Kumar Verma, Praveen Kumar Kampalli, Saikrishna Lakkakula, Gayathri Chalikonda, Bhaskar V.K.S. Lakkakula* and Smaranika Pattnaik

Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-Pharmacodynamic Model

Volume:20
Ya-ou Liu, Zi-ning Wang, Chao-yang Chen, Xian-han Zhuang, Chang-geng Ruan, Ying Zhou and Yi-min Cui*

Naphthalene Toxicity in Clinical Practice

Volume:20
Ashok Kumar Pannu* and Vidhi Singla

Pharmacokinetic Evaluation of 99mTc-radiolabeld Solid Lipid Nanoparticles and Chitosan Coated Solid Lipid Nanoparticles

Volume:20
Nasrin Abbasi, Sajjad Molavipordanjani, Jafar Akbari and Seyed Jalal Hosseinimehr*

Novel Phytochemical Constituents and Anticancer Activities of the Genus, Typhonium

Volume:20
Shaik Ibrahim Khalivulla, Arifullah Mohammed*, Kuttulebbai Nainamohamed Ainamohamed Salam Sirajudeen, Mannur Ismail Shaik, Weibing Ye and Mallikarjuna Korivi*

Sexual Dimorphism in Drug Metabolism and Pharmacokinetics

Volume:20
Askhi M. Valodara and Kaid Johar SR*

Curcumin - A Novel Therapeutic Agent in the Prevention of Colorectal Cancer

Volume:20
Manoj Kumar Gupta, Ramakrishna Vadde and Vemula Sarojamma*

Oral Delivery of Anticancer Agents using Nanoparticulate Drug Delivery System

Volume:20
Prateek Mathur, Shruti Rawal, Bhoomika Patel and Mayur M. Patel*

Mitochondrial Metabolism in Cancer Cachexia: Novel Drug Target

Volume:20
Dhwani T. Dave and Bhoomika M. Patel*

Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients

Volume:19
Eleonore Frohlich*

Interindividual Variability in Drug Metabolizing Enzymes

Volume:19
Donna A. Volpe*